Xeris Pharmaceuticals
XERS
#4026
Rank
$3.03 B
Marketcap
$16.62
Share price
-2.18%
Change (1 day)
134.41%
Change (1 year)

EPS for Xeris Pharmaceuticals (XERS)

EPS in 2026 (TTM): -$0.04000

According to Xeris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.04000. In 2025 the company made an earnings per share (EPS) of $0.0000000000 an increase over its 2024 EPS that were of -$0.38.

EPS history for Xeris Pharmaceuticals from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$0.04000-2.8823037615171E+17%
2025$0.0000000000-100%
2024-$0.38
2022-$0.70-53.95%
2021-$1.52-33.33%
2020-$2.28-52.5%
2019-$4.80-53.17%
2018-$10.25

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-$1.35 3,275.00%๐Ÿ‡บ๐Ÿ‡ธ USA